Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.72934766 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11974549 |
3 | negative regulation of cell killing (GO:0031342) | 5.11974549 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.04073288 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.04073288 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.04073288 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.04073288 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.04073288 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.04073288 |
10 | neutrophil activation involved in immune response (GO:0002283) | 4.86249399 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 4.85506004 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.66712531 |
13 | definitive hemopoiesis (GO:0060216) | 4.62259725 |
14 | response to peptidoglycan (GO:0032494) | 4.58677099 |
15 | immunoglobulin mediated immune response (GO:0016064) | 4.31606316 |
16 | detection of bacterium (GO:0016045) | 4.28479233 |
17 | positive regulation of interferon-alpha production (GO:0032727) | 4.15117278 |
18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.12526789 |
19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.11648560 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.07385677 |
21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.05598726 |
22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.01289623 |
23 | positive regulation of mast cell activation (GO:0033005) | 3.99637116 |
24 | microglial cell activation (GO:0001774) | 3.94611391 |
25 | defense response to protozoan (GO:0042832) | 3.93776369 |
26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93547174 |
27 | regulation of interferon-alpha production (GO:0032647) | 3.88752917 |
28 | positive regulation of B cell differentiation (GO:0045579) | 3.84491909 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83587797 |
30 | response to interferon-beta (GO:0035456) | 3.83409593 |
31 | response to interferon-alpha (GO:0035455) | 3.80059419 |
32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77801033 |
33 | myeloid cell activation involved in immune response (GO:0002275) | 3.75947150 |
34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.69430990 |
35 | detection of biotic stimulus (GO:0009595) | 3.66996351 |
36 | positive regulation of mast cell degranulation (GO:0043306) | 3.66735445 |
37 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.66735445 |
38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.65090711 |
39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.65090711 |
40 | T-helper 1 type immune response (GO:0042088) | 3.63690303 |
41 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.62646207 |
42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61642293 |
43 | response to host immune response (GO:0052572) | 3.61642293 |
44 | respiratory burst (GO:0045730) | 3.60027311 |
45 | endosome to melanosome transport (GO:0035646) | 3.58905551 |
46 | endosome to pigment granule transport (GO:0043485) | 3.58905551 |
47 | response to protozoan (GO:0001562) | 3.58206464 |
48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.54467767 |
49 | regulation of leukocyte degranulation (GO:0043300) | 3.54148588 |
50 | mature B cell differentiation involved in immune response (GO:0002313) | 3.52382233 |
51 | leukocyte aggregation (GO:0070486) | 3.52328211 |
52 | cellular response to type I interferon (GO:0071357) | 3.51263922 |
53 | type I interferon signaling pathway (GO:0060337) | 3.51263922 |
54 | neutrophil activation (GO:0042119) | 3.48458283 |
55 | response to type I interferon (GO:0034340) | 3.48193986 |
56 | detection of other organism (GO:0098543) | 3.46622195 |
57 | platelet dense granule organization (GO:0060155) | 3.44290556 |
58 | megakaryocyte development (GO:0035855) | 3.40382153 |
59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39846224 |
60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39010136 |
61 | granulocyte activation (GO:0036230) | 3.39008433 |
62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37083457 |
63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36402696 |
64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.35696978 |
65 | mast cell activation (GO:0045576) | 3.34383568 |
66 | response to host (GO:0075136) | 3.33699938 |
67 | response to host defenses (GO:0052200) | 3.33699938 |
68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.33699938 |
69 | cellular extravasation (GO:0045123) | 3.33583137 |
70 | negative regulation of interleukin-17 production (GO:0032700) | 3.31917902 |
71 | mature B cell differentiation (GO:0002335) | 3.28427334 |
72 | phagocytosis, engulfment (GO:0006911) | 3.26912450 |
73 | B cell mediated immunity (GO:0019724) | 3.26108929 |
74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.25868894 |
75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24616300 |
76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23738136 |
77 | regulation of B cell differentiation (GO:0045577) | 3.22669091 |
78 | regulation of mast cell activation (GO:0033003) | 3.21731563 |
79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21553678 |
80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21423627 |
81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20938953 |
82 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20768484 |
83 | myeloid dendritic cell activation (GO:0001773) | 3.20636593 |
84 | superoxide anion generation (GO:0042554) | 3.19431496 |
85 | regulation of mast cell degranulation (GO:0043304) | 3.18486532 |
86 | macrophage activation (GO:0042116) | 3.18187516 |
87 | negative regulation of granulocyte differentiation (GO:0030853) | 3.17009267 |
88 | detection of molecule of bacterial origin (GO:0032490) | 3.15678352 |
89 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.15434765 |
90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15122877 |
91 | negative regulation of viral genome replication (GO:0045071) | 3.14265407 |
92 | neutrophil mediated immunity (GO:0002446) | 3.13115906 |
93 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.13097977 |
94 | response to muramyl dipeptide (GO:0032495) | 3.12983074 |
95 | germinal center formation (GO:0002467) | 3.12800006 |
96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11779459 |
97 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10985072 |
98 | pinocytosis (GO:0006907) | 3.06299672 |
99 | lymph node development (GO:0048535) | 3.04979035 |
100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03860917 |
101 | positive regulation of interferon-beta production (GO:0032728) | 3.03498350 |
102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02280173 |
103 | myeloid leukocyte activation (GO:0002274) | 2.97829936 |
104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96665110 |
105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94541010 |
106 | regulation of regulated secretory pathway (GO:1903305) | 2.94054443 |
107 | positive regulation of leukocyte degranulation (GO:0043302) | 2.94030557 |
108 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.93100279 |
109 | leukocyte degranulation (GO:0043299) | 2.92547819 |
110 | ribosomal small subunit assembly (GO:0000028) | 2.88683264 |
111 | positive regulation of lymphocyte migration (GO:2000403) | 2.87069937 |
112 | regulation of tolerance induction (GO:0002643) | 2.86442678 |
113 | positive regulation of macrophage differentiation (GO:0045651) | 2.84782113 |
114 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84724167 |
115 | positive thymic T cell selection (GO:0045059) | 2.83380162 |
116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83066891 |
117 | negative regulation of interleukin-6 production (GO:0032715) | 2.82774164 |
118 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82746077 |
119 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.82600240 |
120 | detection of external biotic stimulus (GO:0098581) | 2.82148425 |
121 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81661641 |
122 | regulation of antigen processing and presentation (GO:0002577) | 2.81643221 |
123 | myeloid dendritic cell differentiation (GO:0043011) | 2.81614556 |
124 | B cell receptor signaling pathway (GO:0050853) | 2.80434127 |
125 | regulation of interleukin-17 production (GO:0032660) | 2.80013935 |
126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79436537 |
127 | negative regulation of innate immune response (GO:0045824) | 2.78359926 |
128 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.78305591 |
129 | regulation of T cell tolerance induction (GO:0002664) | 2.77658681 |
130 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76993145 |
131 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.75696312 |
132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75024369 |
133 | positive regulation of T cell migration (GO:2000406) | 2.74842990 |
134 | T cell migration (GO:0072678) | 2.74303360 |
135 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.74015244 |
136 | myeloid leukocyte mediated immunity (GO:0002444) | 2.71458049 |
137 | neutrophil chemotaxis (GO:0030593) | 2.70126520 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.48853800 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40313978 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.79190819 |
4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.64779563 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.33019124 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.25117948 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.91635158 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.83271978 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.54016847 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32028057 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28699986 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.24873000 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23660342 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.14147848 |
15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92352063 |
16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84159966 |
17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.72218434 |
18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69226756 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.60022571 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49312124 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48785419 |
22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40712561 |
23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32226266 |
24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.28212062 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18274718 |
26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06982264 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05794308 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00130893 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90645289 |
30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90220377 |
31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.90044811 |
32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89558884 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87505313 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83564014 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81238406 |
36 | MYB_26560356_Chip-Seq_TH2_Human | 1.80261284 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79956902 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78549419 |
39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75523080 |
40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75246308 |
41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73884294 |
42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69479521 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.68547046 |
44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65482945 |
45 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61612207 |
46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59508673 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57982082 |
48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56599880 |
49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55675744 |
50 | MYB_26560356_Chip-Seq_TH1_Human | 1.54527225 |
51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51768320 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50473914 |
53 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46963760 |
54 | MAF_26560356_Chip-Seq_TH1_Human | 1.46716348 |
55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42963345 |
56 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38500338 |
57 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36093306 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35305745 |
59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27684745 |
60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25451816 |
61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23356198 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21940171 |
63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20710283 |
64 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20053397 |
65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18477168 |
66 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16444607 |
67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15826598 |
68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15670941 |
69 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.15389943 |
70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12625848 |
71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12488889 |
72 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11961126 |
73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10502760 |
74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10142541 |
75 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08178019 |
76 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05474514 |
77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05192632 |
78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05087332 |
79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04106361 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03450355 |
81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03055476 |
82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02387683 |
83 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.00510494 |
84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97415444 |
85 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.95144775 |
86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94319213 |
87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93354739 |
88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92359255 |
89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91409081 |
90 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90222310 |
91 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.89522171 |
92 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88203240 |
93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85767500 |
94 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85756032 |
95 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.84666250 |
96 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84367773 |
97 | MYC_22102868_ChIP-Seq_BL_Human | 0.81696839 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81162793 |
99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80921451 |
100 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80579502 |
101 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80443649 |
102 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79259934 |
103 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79226162 |
104 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.78270379 |
105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77073801 |
106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76503292 |
107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76454159 |
108 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74332875 |
109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71718826 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71711805 |
111 | MAF_26560356_Chip-Seq_TH2_Human | 0.71164000 |
112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69404293 |
113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66836275 |
114 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.60560134 |
115 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.60014294 |
116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59054118 |
117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58979717 |
118 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56116066 |
119 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.53024155 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.65179031 |
2 | MP0009785_altered_susceptibility_to | 3.44302495 |
3 | MP0003436_decreased_susceptibility_to | 3.22712039 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.22281230 |
5 | MP0005671_abnormal_response_to | 3.10128633 |
6 | MP0002419_abnormal_innate_immunity | 3.04622197 |
7 | MP0006082_CNS_inflammation | 3.03621141 |
8 | MP0005025_abnormal_response_to | 2.89284153 |
9 | MP0005000_abnormal_immune_tolerance | 2.83189199 |
10 | MP0003724_increased_susceptibility_to | 2.82591733 |
11 | MP0005174_abnormal_tail_pigmentation | 2.81127897 |
12 | MP0000685_abnormal_immune_system | 2.80720504 |
13 | * MP0005464_abnormal_platelet_physiology | 2.80606316 |
14 | MP0005058_abnormal_lysosome_morphology | 2.80313543 |
15 | MP0002452_abnormal_antigen_presenting | 2.66897687 |
16 | MP0001800_abnormal_humoral_immune | 2.50340519 |
17 | MP0000569_abnormal_digit_pigmentation | 2.49964250 |
18 | MP0002723_abnormal_immune_serum | 2.48818421 |
19 | MP0005387_immune_system_phenotype | 2.44319740 |
20 | MP0001790_abnormal_immune_system | 2.44319740 |
21 | MP0001819_abnormal_immune_cell | 2.32026589 |
22 | MP0002420_abnormal_adaptive_immunity | 2.30815035 |
23 | MP0002396_abnormal_hematopoietic_system | 2.28656412 |
24 | MP0003172_abnormal_lysosome_physiology | 2.28540374 |
25 | MP0001545_abnormal_hematopoietic_system | 2.09660130 |
26 | MP0005397_hematopoietic_system_phenotyp | 2.09660130 |
27 | MP0000465_gastrointestinal_hemorrhage | 2.06929496 |
28 | MP0004808_abnormal_hematopoietic_stem | 2.04336390 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.98097935 |
30 | MP0001853_heart_inflammation | 1.91250113 |
31 | MP0002398_abnormal_bone_marrow | 1.87999427 |
32 | MP0000015_abnormal_ear_pigmentation | 1.87330447 |
33 | MP0000716_abnormal_immune_system | 1.80628477 |
34 | MP0010155_abnormal_intestine_physiology | 1.76176812 |
35 | MP0005075_abnormal_melanosome_morpholog | 1.74274011 |
36 | MP0002405_respiratory_system_inflammati | 1.73165806 |
37 | MP0000689_abnormal_spleen_morphology | 1.72501070 |
38 | * MP0001845_abnormal_inflammatory_respons | 1.70354120 |
39 | MP0009278_abnormal_bone_marrow | 1.67646387 |
40 | MP0004510_myositis | 1.65116008 |
41 | MP0001533_abnormal_skeleton_physiology | 1.61777610 |
42 | MP0002429_abnormal_blood_cell | 1.55676782 |
43 | MP0002722_abnormal_immune_system | 1.54027575 |
44 | MP0008469_abnormal_protein_level | 1.53683731 |
45 | MP0009764_decreased_sensitivity_to | 1.50036189 |
46 | MP0002095_abnormal_skin_pigmentation | 1.48973714 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.47417990 |
48 | MP0005310_abnormal_salivary_gland | 1.44443094 |
49 | MP0000490_abnormal_crypts_of | 1.44370365 |
50 | MP0000343_altered_response_to | 1.41172152 |
51 | MP0003075_altered_response_to | 1.41165754 |
52 | MP0003303_peritoneal_inflammation | 1.36084720 |
53 | MP0001873_stomach_inflammation | 1.35926304 |
54 | MP0004947_skin_inflammation | 1.35870483 |
55 | MP0009333_abnormal_splenocyte_physiolog | 1.35754063 |
56 | MP0002166_altered_tumor_susceptibility | 1.34989611 |
57 | MP0002006_tumorigenesis | 1.34927802 |
58 | MP0000604_amyloidosis | 1.34623941 |
59 | MP0003763_abnormal_thymus_physiology | 1.33985331 |
60 | MP0005451_abnormal_body_composition | 1.33269803 |
61 | MP0004883_abnormal_blood_vessel | 1.28288235 |
62 | MP0004147_increased_porphyrin_level | 1.19825459 |
63 | MP0003183_abnormal_peptide_metabolism | 1.17937093 |
64 | MP0003866_abnormal_defecation | 1.14973919 |
65 | MP0003828_pulmonary_edema | 1.14261510 |
66 | MP0002132_abnormal_respiratory_system | 1.09939764 |
67 | MP0002998_abnormal_bone_remodeling | 1.09453633 |
68 | MP0001851_eye_inflammation | 1.08966894 |
69 | MP0005164_abnormal_response_to | 1.07225385 |
70 | MP0005166_decreased_susceptibility_to | 1.03789241 |
71 | MP0001986_abnormal_taste_sensitivity | 1.02681451 |
72 | MP0002933_joint_inflammation | 0.99552684 |
73 | MP0000371_diluted_coat_color | 0.96911851 |
74 | MP0009840_abnormal_foam_cell | 0.96062285 |
75 | MP0009763_increased_sensitivity_to | 0.91146827 |
76 | MP0002277_abnormal_respiratory_mucosa | 0.90460277 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 0.88904270 |
78 | MP0000858_altered_metastatic_potential | 0.88103461 |
79 | MP0003943_abnormal_hepatobiliary_system | 0.87267264 |
80 | MP0003448_altered_tumor_morphology | 0.85826951 |
81 | MP0000703_abnormal_thymus_morphology | 0.85110936 |
82 | MP0005167_abnormal_blood-brain_barrier | 0.81989328 |
83 | MP0003690_abnormal_glial_cell | 0.79277829 |
84 | MP0005390_skeleton_phenotype | 0.77817465 |
85 | MP0008260_abnormal_autophagy | 0.77700291 |
86 | MP0002138_abnormal_hepatobiliary_system | 0.75673985 |
87 | MP0004782_abnormal_surfactant_physiolog | 0.73763070 |
88 | MP0003300_gastrointestinal_ulcer | 0.73395112 |
89 | MP0001188_hyperpigmentation | 0.72607365 |
90 | MP0003186_abnormal_redox_activity | 0.69120436 |
91 | MP0002075_abnormal_coat/hair_pigmentati | 0.68896261 |
92 | MP0008874_decreased_physiological_sensi | 0.68672528 |
93 | MP0002332_abnormal_exercise_endurance | 0.68600061 |
94 | MP0008007_abnormal_cellular_replicative | 0.66675389 |
95 | MP0000681_abnormal_thyroid_gland | 0.66054604 |
96 | MP0000249_abnormal_blood_vessel | 0.65832274 |
97 | MP0003795_abnormal_bone_structure | 0.63954495 |
98 | MP0004381_abnormal_hair_follicle | 0.63821644 |
99 | MP0008058_abnormal_DNA_repair | 0.61944219 |
100 | MP0006054_spinal_hemorrhage | 0.61673933 |
101 | MP0000920_abnormal_myelination | 0.60303612 |
102 | MP0010307_abnormal_tumor_latency | 0.60243876 |
103 | MP0009697_abnormal_copulation | 0.59860029 |
104 | MP0005165_increased_susceptibility_to | 0.59777915 |
105 | MP0003329_amyloid_beta_deposits | 0.59749712 |
106 | MP0001663_abnormal_digestive_system | 0.58770433 |
107 | MP0009765_abnormal_xenobiotic_induced | 0.58745944 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.58546822 |
109 | MP0002139_abnormal_hepatobiliary_system | 0.56543526 |
110 | MP0000372_irregular_coat_pigmentation | 0.56441248 |
111 | MP0000767_abnormal_smooth_muscle | 0.54866566 |
112 | MP0008004_abnormal_stomach_pH | 0.54741589 |
113 | MP0005381_digestive/alimentary_phenotyp | 0.54145000 |
114 | MP0003279_aneurysm | 0.52136100 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.51971966 |
116 | MP0001186_pigmentation_phenotype | 0.50738056 |
117 | MP0005535_abnormal_body_temperature | 0.50433056 |
118 | MP0004130_abnormal_muscle_cell | 0.49269640 |
119 | MP0000609_abnormal_liver_physiology | 0.47356253 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.56452131 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.93087447 |
3 | Eczematoid dermatitis (HP:0000976) | 5.25845660 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.55720631 |
5 | Myositis (HP:0100614) | 4.47125042 |
6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.44951990 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.40832399 |
8 | Increased cerebral lipofuscin (HP:0011813) | 4.34801692 |
9 | Abnormality of macrophages (HP:0004311) | 4.22170688 |
10 | Recurrent skin infections (HP:0001581) | 3.90119145 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.89810368 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89399891 |
13 | Orchitis (HP:0100796) | 3.77751559 |
14 | Thrombocytosis (HP:0001894) | 3.71071770 |
15 | Retrobulbar optic neuritis (HP:0100654) | 3.68635686 |
16 | Optic neuritis (HP:0100653) | 3.68635686 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.61823964 |
18 | Recurrent fungal infections (HP:0002841) | 3.54496872 |
19 | Petechiae (HP:0000967) | 3.50579567 |
20 | Prostate neoplasm (HP:0100787) | 3.40835981 |
21 | * Prolonged bleeding time (HP:0003010) | 3.39007536 |
22 | Periodontitis (HP:0000704) | 3.38962001 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.18014654 |
24 | Glomerulonephritis (HP:0000099) | 3.16356143 |
25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14787440 |
26 | Obstructive lung disease (HP:0006536) | 3.14787440 |
27 | Gingivitis (HP:0000230) | 3.11551458 |
28 | * Epistaxis (HP:0000421) | 3.07607985 |
29 | Cellulitis (HP:0100658) | 3.05296331 |
30 | Recurrent viral infections (HP:0004429) | 3.00766513 |
31 | Arterial thrombosis (HP:0004420) | 3.00231760 |
32 | Abnormality of the prostate (HP:0008775) | 2.99571992 |
33 | IgM deficiency (HP:0002850) | 2.98528412 |
34 | Vasculitis (HP:0002633) | 2.98424371 |
35 | Gingival bleeding (HP:0000225) | 2.98154667 |
36 | Amyloidosis (HP:0011034) | 2.95188135 |
37 | Meningitis (HP:0001287) | 2.87811589 |
38 | Chronic otitis media (HP:0000389) | 2.87687923 |
39 | Agnosia (HP:0010524) | 2.84301983 |
40 | Albinism (HP:0001022) | 2.83775471 |
41 | T lymphocytopenia (HP:0005403) | 2.81910969 |
42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80768918 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80768918 |
44 | Abnormality of T cell number (HP:0011839) | 2.76787392 |
45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74737999 |
46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71526133 |
47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71526133 |
48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71526133 |
49 | Dysostosis multiplex (HP:0000943) | 2.67743950 |
50 | Spontaneous hematomas (HP:0007420) | 2.66654445 |
51 | Autoimmune thrombocytopenia (HP:0001973) | 2.66221047 |
52 | Increased IgE level (HP:0003212) | 2.63607901 |
53 | Purpura (HP:0000979) | 2.63244616 |
54 | Hematochezia (HP:0002573) | 2.61439318 |
55 | Episodic fever (HP:0001954) | 2.60577359 |
56 | Impaired platelet aggregation (HP:0003540) | 2.60285310 |
57 | Abnormal platelet function (HP:0011869) | 2.60285310 |
58 | Increased IgM level (HP:0003496) | 2.59219077 |
59 | Basal ganglia calcification (HP:0002135) | 2.57030695 |
60 | Increased serum ferritin (HP:0003281) | 2.53739896 |
61 | Reduced antithrombin III activity (HP:0001976) | 2.50895705 |
62 | Stomatitis (HP:0010280) | 2.50760145 |
63 | Recurrent pneumonia (HP:0006532) | 2.48876240 |
64 | Pulmonary embolism (HP:0002204) | 2.48473003 |
65 | Gastrointestinal stroma tumor (HP:0100723) | 2.43411552 |
66 | Disinhibition (HP:0000734) | 2.42323553 |
67 | Osteomyelitis (HP:0002754) | 2.40885410 |
68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40564842 |
69 | Anorexia (HP:0002039) | 2.37439254 |
70 | Abnormality of T cells (HP:0002843) | 2.35520750 |
71 | Abnormality of iron homeostasis (HP:0011031) | 2.34855557 |
72 | Axonal loss (HP:0003447) | 2.31690373 |
73 | Leukocytosis (HP:0001974) | 2.30996790 |
74 | Pustule (HP:0200039) | 2.29792203 |
75 | Menorrhagia (HP:0000132) | 2.28937558 |
76 | Gangrene (HP:0100758) | 2.28721808 |
77 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.27542348 |
78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25333010 |
79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25333010 |
80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25333010 |
81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25294953 |
82 | Mucopolysacchariduria (HP:0008155) | 2.25294953 |
83 | Chronic diarrhea (HP:0002028) | 2.24111619 |
84 | Granulocytopenia (HP:0001913) | 2.24109141 |
85 | Keratoconjunctivitis sicca (HP:0001097) | 2.23180813 |
86 | Amaurosis fugax (HP:0100576) | 2.22554079 |
87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22466311 |
88 | Vertigo (HP:0002321) | 2.20865054 |
89 | Thoracic kyphosis (HP:0002942) | 2.20468225 |
90 | Mutism (HP:0002300) | 2.19113303 |
91 | Hemoptysis (HP:0002105) | 2.18974082 |
92 | Type I transferrin isoform profile (HP:0003642) | 2.17807214 |
93 | Urticaria (HP:0001025) | 2.17450588 |
94 | Abnormality of the pleura (HP:0002103) | 2.16512960 |
95 | Agammaglobulinemia (HP:0004432) | 2.16406809 |
96 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15457513 |
97 | Polyneuropathy (HP:0001271) | 2.15412439 |
98 | Interstitial pulmonary disease (HP:0006530) | 2.15259965 |
99 | Pulmonary infiltrates (HP:0002113) | 2.15069227 |
100 | Panhypogammaglobulinemia (HP:0003139) | 2.13585729 |
101 | Hypergammaglobulinemia (HP:0010702) | 2.12707444 |
102 | Autoimmune hemolytic anemia (HP:0001890) | 2.09429576 |
103 | Inflammation of the large intestine (HP:0002037) | 2.09157396 |
104 | Aplastic anemia (HP:0001915) | 2.09033386 |
105 | Hypothermia (HP:0002045) | 2.07556325 |
106 | Loss of speech (HP:0002371) | 2.06673762 |
107 | Lymphopenia (HP:0001888) | 2.05365404 |
108 | Abnormal platelet volume (HP:0011876) | 2.05066813 |
109 | Glomerulopathy (HP:0100820) | 2.04247224 |
110 | Premature loss of primary teeth (HP:0006323) | 2.04166211 |
111 | Acute myeloid leukemia (HP:0004808) | 2.03820139 |
112 | Keratoconjunctivitis (HP:0001096) | 2.01862908 |
113 | Hepatosplenomegaly (HP:0001433) | 2.01170167 |
114 | Abnormality of T cell physiology (HP:0011840) | 2.00479686 |
115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98951643 |
116 | Gastrointestinal inflammation (HP:0004386) | 1.98944071 |
117 | Hypochromic anemia (HP:0001931) | 1.98371017 |
118 | Encephalitis (HP:0002383) | 1.98212148 |
119 | Peritonitis (HP:0002586) | 1.97719142 |
120 | Sepsis (HP:0100806) | 1.96775769 |
121 | Chest pain (HP:0100749) | 1.94918172 |
122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94275557 |
123 | Nephritis (HP:0000123) | 1.93405983 |
124 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93055354 |
125 | Colitis (HP:0002583) | 1.92514644 |
126 | Poikiloderma (HP:0001029) | 1.91989726 |
127 | J-shaped sella turcica (HP:0002680) | 1.91118096 |
128 | Eosinophilia (HP:0001880) | 1.91027734 |
129 | Hypochromic microcytic anemia (HP:0004840) | 1.89329840 |
130 | Acne (HP:0001061) | 1.85569629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KIT | 3.70907331 |
2 | RIPK4 | 3.55262361 |
3 | IRAK4 | 3.17075476 |
4 | TGFBR2 | 3.01354323 |
5 | BLK | 2.85979310 |
6 | IRAK3 | 2.74475670 |
7 | MAP3K14 | 2.68011626 |
8 | MAP4K1 | 2.63989041 |
9 | TXK | 2.62023557 |
10 | TBK1 | 2.30733381 |
11 | TEC | 2.16959558 |
12 | IKBKE | 2.09889397 |
13 | TNIK | 2.07777099 |
14 | JAK3 | 2.06957857 |
15 | GRK6 | 2.06807999 |
16 | FGR | 2.05754477 |
17 | CSF1R | 2.05624504 |
18 | IKBKB | 2.04075587 |
19 | TYK2 | 1.93050644 |
20 | BTK | 1.93034499 |
21 | MATK | 1.93005985 |
22 | TGFBR1 | 1.92838078 |
23 | NME2 | 1.89217166 |
24 | MAP3K11 | 1.84317151 |
25 | PRPF4B | 1.73537325 |
26 | MAP3K3 | 1.68109651 |
27 | TIE1 | 1.66836982 |
28 | MAP2K3 | 1.65815413 |
29 | TAOK1 | 1.52734764 |
30 | ACVR1B | 1.50793367 |
31 | SYK | 1.50070523 |
32 | MUSK | 1.49375078 |
33 | ZAP70 | 1.47073551 |
34 | FES | 1.44391327 |
35 | ADRBK2 | 1.42036304 |
36 | BMPR1B | 1.38685895 |
37 | PIK3CG | 1.38264753 |
38 | TAOK3 | 1.37665672 |
39 | PIM2 | 1.36713841 |
40 | MAP3K12 | 1.35483343 |
41 | LYN | 1.33537169 |
42 | GRK7 | 1.32499474 |
43 | TAOK2 | 1.30561314 |
44 | FLT3 | 1.29564704 |
45 | MAP3K1 | 1.27938248 |
46 | LCK | 1.18029558 |
47 | YES1 | 1.16331385 |
48 | HCK | 1.14179051 |
49 | JAK1 | 1.09629234 |
50 | TESK2 | 1.08915286 |
51 | CHUK | 1.04963673 |
52 | NLK | 1.01449818 |
53 | CAMK1D | 0.95686382 |
54 | SIK3 | 0.93328956 |
55 | PIM1 | 0.93289674 |
56 | IRAK1 | 0.90972745 |
57 | MAP3K13 | 0.88140744 |
58 | CAMKK2 | 0.87684292 |
59 | MKNK1 | 0.85391426 |
60 | CLK1 | 0.84872831 |
61 | CDK8 | 0.84690979 |
62 | CDK19 | 0.82246303 |
63 | NEK9 | 0.82087280 |
64 | DAPK2 | 0.79850537 |
65 | EIF2AK2 | 0.77592273 |
66 | RPS6KA4 | 0.69495421 |
67 | PDPK1 | 0.69172578 |
68 | BCKDK | 0.68888859 |
69 | VRK1 | 0.68871893 |
70 | MAP3K5 | 0.67817156 |
71 | CSK | 0.66077687 |
72 | MAPKAPK5 | 0.66037107 |
73 | TRPM7 | 0.63440179 |
74 | MARK2 | 0.60710034 |
75 | STK16 | 0.60531795 |
76 | JAK2 | 0.60273116 |
77 | MOS | 0.59330450 |
78 | FYN | 0.58342808 |
79 | LRRK2 | 0.58264255 |
80 | KSR2 | 0.57970713 |
81 | ERN1 | 0.57938838 |
82 | PTK2B | 0.57772994 |
83 | MAPK15 | 0.57702758 |
84 | CDC42BPA | 0.56824173 |
85 | PRKCQ | 0.54565594 |
86 | PRKCD | 0.54136231 |
87 | MAP3K6 | 0.52090103 |
88 | PRKG2 | 0.51204883 |
89 | MARK3 | 0.50055459 |
90 | MAPK7 | 0.47760842 |
91 | CCNB1 | 0.47206366 |
92 | PRKD2 | 0.46735127 |
93 | FGFR3 | 0.46675844 |
94 | HIPK2 | 0.46665776 |
95 | MKNK2 | 0.46508956 |
96 | ITK | 0.46502885 |
97 | RPS6KA6 | 0.46136449 |
98 | STK4 | 0.46015917 |
99 | CDK6 | 0.44825330 |
100 | MAP2K6 | 0.44696217 |
101 | IRAK2 | 0.44171467 |
102 | BMPR2 | 0.42442762 |
103 | CAMKK1 | 0.41906452 |
104 | MAP2K7 | 0.40171951 |
105 | ABL1 | 0.39509149 |
106 | ZAK | 0.39414573 |
107 | PAK4 | 0.38988927 |
108 | BMX | 0.38982221 |
109 | PIK3CA | 0.38904561 |
110 | MAPK4 | 0.37823118 |
111 | DYRK1B | 0.37495506 |
112 | TNK2 | 0.36959911 |
113 | NEK6 | 0.36504859 |
114 | PTK6 | 0.36064554 |
115 | STK10 | 0.35474006 |
116 | SIK2 | 0.35184891 |
117 | EPHA3 | 0.34786359 |
118 | MAP3K2 | 0.33958668 |
119 | RPS6KA5 | 0.33395120 |
120 | MAPK12 | 0.32718137 |
121 | EPHB1 | 0.32632982 |
122 | MAP2K4 | 0.31641991 |
123 | IGF1R | 0.29954738 |
124 | RPS6KB2 | 0.29903697 |
125 | KDR | 0.29108380 |
126 | MAPKAPK2 | 0.28632765 |
127 | ABL2 | 0.28567548 |
128 | MAPK3 | 0.28534226 |
129 | RPS6KC1 | 0.28497829 |
130 | RPS6KL1 | 0.28497829 |
131 | EEF2K | 0.28423773 |
132 | RAF1 | 0.27950926 |
133 | CAMK1 | 0.27307444 |
134 | PDK1 | 0.27219176 |
135 | STK11 | 0.23990520 |
136 | GRK5 | 0.22657562 |
137 | PRKD1 | 0.21701870 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24480181 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.94423185 |
3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.67397532 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54561868 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.49723263 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45046040 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.32514772 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31337329 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30876681 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.20320455 |
11 | Measles_Homo sapiens_hsa05162 | 2.14639691 |
12 | Legionellosis_Homo sapiens_hsa05134 | 2.13861489 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12600633 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06548263 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06337319 |
16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97520344 |
17 | Malaria_Homo sapiens_hsa05144 | 1.94714396 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 1.94175870 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91503703 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91489091 |
21 | Lysosome_Homo sapiens_hsa04142 | 1.89943535 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.88163366 |
23 | Asthma_Homo sapiens_hsa05310 | 1.75514988 |
24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70174045 |
25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61843251 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60755888 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.60231022 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60224308 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59969020 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47833411 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39130933 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37579722 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.34828809 |
34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34033789 |
35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30098078 |
36 | Phagosome_Homo sapiens_hsa04145 | 1.28214507 |
37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22622734 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19149212 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18937176 |
40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15139959 |
41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14871234 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.14436333 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.13959556 |
44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09999122 |
45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09834277 |
46 | * Platelet activation_Homo sapiens_hsa04611 | 1.08822991 |
47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08640134 |
48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08054716 |
49 | Hepatitis B_Homo sapiens_hsa05161 | 1.07916862 |
50 | Ribosome_Homo sapiens_hsa03010 | 1.04823078 |
51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01811430 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98178987 |
53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96749699 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92431288 |
55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86289632 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84163008 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 0.82305024 |
58 | DNA replication_Homo sapiens_hsa03030 | 0.78675486 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77020535 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76887229 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76598813 |
62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74782113 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74178220 |
64 | Base excision repair_Homo sapiens_hsa03410 | 0.73557458 |
65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72175931 |
66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69705051 |
67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68122563 |
68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67106880 |
69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66152281 |
70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64580453 |
71 | Homologous recombination_Homo sapiens_hsa03440 | 0.64303471 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63788524 |
73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61824745 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.55765382 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54651423 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53681661 |
77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53288397 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52852939 |
79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52395974 |
80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51410917 |
81 | Mismatch repair_Homo sapiens_hsa03430 | 0.51138623 |
82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50169670 |
83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48804249 |
84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47423485 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46385526 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44936280 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.41993688 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41521639 |
89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40337105 |
90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39285791 |
91 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37813369 |
92 | Amoebiasis_Homo sapiens_hsa05146 | 0.36812355 |
93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35593429 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34900373 |
95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34466658 |
96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34383885 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33909622 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32533585 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31714764 |
100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31669714 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30025427 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29208711 |
103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28659035 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28246856 |
105 | Bladder cancer_Homo sapiens_hsa05219 | 0.28017829 |
106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27192594 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26785662 |
108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26372327 |
109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25571200 |
110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.25405391 |
111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25164402 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25039943 |
113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.24430269 |
114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24027310 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22313402 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.21923700 |
117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21119063 |
118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20900254 |
119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20867105 |
120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20770508 |
121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20343106 |
122 | Prion diseases_Homo sapiens_hsa05020 | 0.19504324 |